37 related articles for article (PubMed ID: 18501097)
1. Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening.
Nofal S; Niu J; Resong P; Jin J; Merriman KW; Le X; Katki H; Heymach J; Antonoff MB; Ostrin E; Wu J; Zhang J; Toumazis I
Cancer Med; 2024 Mar; 13(5):e7069. PubMed ID: 38466021
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis.
Al-Husseini MJ; Kunbaz A; Saad AM; Santos JV; Salahia S; Iqbal M; Alahdab F
BMC Cancer; 2019 Jan; 19(1):46. PubMed ID: 30630456
[TBL] [Abstract][Full Text] [Related]
3. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer.
Morris LG; Sikora AG; Hayes RB; Patel SG; Ganly I
Cancer Causes Control; 2011 May; 22(5):671-9. PubMed ID: 21327458
[TBL] [Abstract][Full Text] [Related]
4. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
[TBL] [Abstract][Full Text] [Related]
5. Incidence of second malignancies in patients with thymic carcinoma and thymic neuroendocrine tumor.
Qiu G; Wang F; Wang Y
J Cancer Res Clin Oncol; 2024 Jan; 150(1):11. PubMed ID: 38227201
[TBL] [Abstract][Full Text] [Related]
6. Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis.
Banner L; Rohan TZ; Zachian R; Gross T; Yang HY; Joffe D; Porcu P; Nikbakht N
J Am Acad Dermatol; 2024 Mar; ():. PubMed ID: 38513830
[No Abstract] [Full Text] [Related]
7. Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer.
Li Y; Xu X; Song L; Hou Y; Li Z; Tsang S; Li F; Im KM; Wu K; Wu H; Ye X; Li G; Wang L; Zhang B; Liang J; Xie W; Wu R; Jiang H; Liu X; Yu C; Zheng H; Jian M; Nie L; Wan L; Shi M; Sun X; Tang A; Guo G; Gui Y; Cai Z; Li J; Wang W; Lu Z; Zhang X; Bolund L; Kristiansen K; Wang J; Yang H; Dean M; Wang J
Gigascience; 2012 Aug; 1(1):12. PubMed ID: 23587365
[TBL] [Abstract][Full Text] [Related]
8. Bladder cancer in cancer patients: population-based estimates from a large Swedish study.
Bermejo JL; Sundquist J; Hemminki K
Br J Cancer; 2009 Oct; 101(7):1091-9. PubMed ID: 19755987
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of cancer in the United States.
Cresanta JL
Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
[TBL] [Abstract][Full Text] [Related]
10. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
11. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials.
Rusthoven KE; Flaig TW; Raben D; Kavanagh BD
Clin Lung Cancer; 2008 Mar; 9(2):106-11. PubMed ID: 18501097
[TBL] [Abstract][Full Text] [Related]
12. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
[TBL] [Abstract][Full Text] [Related]
13. High incidence of independent second malignancies after non-muscle-invasive bladder cancer.
Zecha H; Schmid HP; Tschopp A; Sulser T; Engeler DS
Scand J Urol Nephrol; 2011 Sep; 45(4):245-50. PubMed ID: 21443417
[TBL] [Abstract][Full Text] [Related]
14. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
